153 related articles for article (PubMed ID: 17895366)
21. Affinity regulates spatial range of EGF receptor autocrine ligand binding.
DeWitt A; Iida T; Lam HY; Hill V; Wiley HS; Lauffenburger DA
Dev Biol; 2002 Oct; 250(2):305-16. PubMed ID: 12376105
[TBL] [Abstract][Full Text] [Related]
22. Induced autocrine signaling through the epidermal growth factor receptor contributes to the response of mammary epithelial cells to tumor necrosis factor alpha.
Chen WN; Woodbury RL; Kathmann LE; Opresko LK; Zangar RC; Wiley HS; Thrall BD
J Biol Chem; 2004 Apr; 279(18):18488-96. PubMed ID: 14978035
[TBL] [Abstract][Full Text] [Related]
23. Autocrine signal transmission with extracellular ligand degradation.
Muratov CB; Posta F; Shvartsman SY
Phys Biol; 2009 Feb; 6(1):016006. PubMed ID: 19234361
[TBL] [Abstract][Full Text] [Related]
24. Whey acidic protein (WAP) regulates the proliferation of mammary epithelial cells by preventing serine protease from degrading laminin.
Nukumi N; Iwamori T; Kano K; Naito K; Tojo H
J Cell Physiol; 2007 Dec; 213(3):793-800. PubMed ID: 17541952
[TBL] [Abstract][Full Text] [Related]
25. A reduction of epidermal growth factor receptor is involved in brefelamide-induced inhibition of phosphorylation of ERK in human astrocytoma cells.
Honma S; Saito M; Kikuchi H; Saito Y; Oshima Y; Nakahata N; Yoshida M
Eur J Pharmacol; 2009 Aug; 616(1-3):38-42. PubMed ID: 19559020
[TBL] [Abstract][Full Text] [Related]
26. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor.
Dong J; Opresko LK; Dempsey PJ; Lauffenburger DA; Coffey RJ; Wiley HS
Proc Natl Acad Sci U S A; 1999 May; 96(11):6235-40. PubMed ID: 10339571
[TBL] [Abstract][Full Text] [Related]
27. Expression of a functional epidermal growth factor receptor on human adipose-derived mesenchymal stem cells and its signaling mechanism.
Baer PC; Schubert R; Bereiter-Hahn J; Plösser M; Geiger H
Eur J Cell Biol; 2009 May; 88(5):273-83. PubMed ID: 19167776
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
29. c-Fos accelerates hepatocyte conversion to a fibroblastoid phenotype through ERK-mediated upregulation of paxillin-Serine178 phosphorylation.
Güller MC; André J; Legrand A; Setterblad N; Mauviel A; Verrecchia F; Daniel F; Bernuau D
Mol Carcinog; 2009 Jun; 48(6):532-44. PubMed ID: 18973190
[TBL] [Abstract][Full Text] [Related]
30. Syndecan-1 regulates FGF8b responses in S115 mammary carcinoma cells.
Viklund L; Vorontsova N; Henttinen T; Salmivirta M
Growth Factors; 2006 Jun; 24(2):151-7. PubMed ID: 16801134
[TBL] [Abstract][Full Text] [Related]
31. Structure of the EGF receptor transactivation circuit integrates multiple signals with cell context.
Joslin EJ; Shankaran H; Opresko LK; Bollinger N; Lauffenburger DA; Wiley HS
Mol Biosyst; 2010 Jul; 6(7):1293-306. PubMed ID: 20458382
[TBL] [Abstract][Full Text] [Related]
32. Autocrine and paracrine signaling through neuropeptide receptors in human cancer.
Heasley LE
Oncogene; 2001 Mar; 20(13):1563-9. PubMed ID: 11313903
[TBL] [Abstract][Full Text] [Related]
33. An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand.
Wilsbacher JL; Moores SL; Brugge JS
Cell Commun Signal; 2006 May; 4():5. PubMed ID: 16709244
[TBL] [Abstract][Full Text] [Related]
34. External and internal EGFR-activating signals drive mammary epithelial cells proliferation and viability.
Morato A; Martignani E; Miretti S; Baratta M; Accornero P
Mol Cell Endocrinol; 2021 Jan; 520():111081. PubMed ID: 33181234
[TBL] [Abstract][Full Text] [Related]
35. Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands.
Higashiyama S; Nanba D; Nakayama H; Inoue H; Fukuda S
J Biochem; 2011 Jul; 150(1):15-22. PubMed ID: 21610047
[TBL] [Abstract][Full Text] [Related]
36. An integrated agent-mathematical model of the effect of intercellular signalling via the epidermal growth factor receptor on cell proliferation.
Walker D; Wood S; Southgate J; Holcombe M; Smallwood R
J Theor Biol; 2006 Oct; 242(3):774-89. PubMed ID: 16765384
[TBL] [Abstract][Full Text] [Related]
37. Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
Miller MA; Moss ML; Powell G; Petrovich R; Edwards L; Meyer AS; Griffith LG; Lauffenburger DA
Sci Rep; 2015 Oct; 5():15150. PubMed ID: 26477568
[TBL] [Abstract][Full Text] [Related]
38. EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.
Tarcic G; Avraham R; Pines G; Amit I; Shay T; Lu Y; Zwang Y; Katz M; Ben-Chetrit N; Jacob-Hirsch J; Virgilio L; Rechavi G; Mavrothalassitis G; Mills GB; Domany E; Yarden Y
FASEB J; 2012 Apr; 26(4):1582-92. PubMed ID: 22198386
[TBL] [Abstract][Full Text] [Related]
39. Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells.
Kumar N; Afeyan R; Kim HD; Lauffenburger DA
Mol Pharmacol; 2008 Jun; 73(6):1668-78. PubMed ID: 18349105
[TBL] [Abstract][Full Text] [Related]
40. Substratum stiffness regulates Erk signaling dynamics through receptor-level control.
Farahani PE; Lemke SB; Dine E; Uribe G; Toettcher JE; Nelson CM
Cell Rep; 2021 Dec; 37(13):110181. PubMed ID: 34965432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]